Bis-pyrimidine acetamides: Design, synthesis and biological evaluation

Background: In the past few years, increased resistance of microorganisms towards antimicrobial agents become a serious health problem, so there is a need for the discovery of new antimicrobial agents. On the other hand, bis-pyrimidines possess various types of biological activity. In view of this,...

Full description

Bibliographic Details
Published in:Chemistry Central Journal
Main Author: Kumar S.; Lim S.M.; Ramasamy K.; Vasudevan M.; Shah S.A.A.; Narasimhan B.
Format: Article
Language:English
Published: BioMed Central Ltd. 2017
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027117501&doi=10.1186%2fs13065-017-0312-2&partnerID=40&md5=4206eaa1c3de0b7b4c69a4ef6bc0cbd9
id 2-s2.0-85027117501
spelling 2-s2.0-85027117501
Kumar S.; Lim S.M.; Ramasamy K.; Vasudevan M.; Shah S.A.A.; Narasimhan B.
Bis-pyrimidine acetamides: Design, synthesis and biological evaluation
2017
Chemistry Central Journal
11
1
10.1186/s13065-017-0312-2
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027117501&doi=10.1186%2fs13065-017-0312-2&partnerID=40&md5=4206eaa1c3de0b7b4c69a4ef6bc0cbd9
Background: In the past few years, increased resistance of microorganisms towards antimicrobial agents become a serious health problem, so there is a need for the discovery of new antimicrobial agents. On the other hand, bis-pyrimidines possess various types of biological activity. In view of this, in the present study we have designed and synthesized a new series of bis-pyrimidine acetamides by Claisen-Schmidt condensation and screened for its in vitro antimicrobial and anticancer activities. Results: The synthesized bis-pyrimidine acetamide derivatives were confirmed by IR, 1H/13C-NMR, Mass spectral studies as well C, H, N analyses. The synthesized compounds were evaluated for their in vitro antimicrobial potential against Gram positive (Staphylococcus aureus and Bacillus subtilis); Gram negative (Escherichia coli, Pseudomonas aeruginosa and Salmonella enterica) bacterial and fungal (Candida albicans and Aspergillus niger) strains by tube dilution technique and the minimum inhibitory concentration (MIC) recorded in μmol/mL was comparable to reference drugs, cefadroxil (antibacterial) and fluconazole (antifungal). The in vitro anticancer activity (IC50 value) determined against human colorectal carcinoma (HCT116) cancer cell line by Sulforhodamine B (SRB) technique and 5-fluorouracil used as reference drug. Conclusions: The biological study demonstrated that compounds 3, 13, 16, 17 and 18 were found to be most active antimicrobial agents with best MIC values than the cefadroxil (antibacterial) and fluconazole (antifungal) and compounds 12, 16 and 18 found to have better anticancer activity against human colorectal carcinoma (HCT116) cancer cell line with best IC50 value than the 5-fluorouracil (anticancer).[Figure not available: see fulltext.] © 2017 The Author(s).
BioMed Central Ltd.
1752153X
English
Article
All Open Access; Gold Open Access
author Kumar S.; Lim S.M.; Ramasamy K.; Vasudevan M.; Shah S.A.A.; Narasimhan B.
spellingShingle Kumar S.; Lim S.M.; Ramasamy K.; Vasudevan M.; Shah S.A.A.; Narasimhan B.
Bis-pyrimidine acetamides: Design, synthesis and biological evaluation
author_facet Kumar S.; Lim S.M.; Ramasamy K.; Vasudevan M.; Shah S.A.A.; Narasimhan B.
author_sort Kumar S.; Lim S.M.; Ramasamy K.; Vasudevan M.; Shah S.A.A.; Narasimhan B.
title Bis-pyrimidine acetamides: Design, synthesis and biological evaluation
title_short Bis-pyrimidine acetamides: Design, synthesis and biological evaluation
title_full Bis-pyrimidine acetamides: Design, synthesis and biological evaluation
title_fullStr Bis-pyrimidine acetamides: Design, synthesis and biological evaluation
title_full_unstemmed Bis-pyrimidine acetamides: Design, synthesis and biological evaluation
title_sort Bis-pyrimidine acetamides: Design, synthesis and biological evaluation
publishDate 2017
container_title Chemistry Central Journal
container_volume 11
container_issue 1
doi_str_mv 10.1186/s13065-017-0312-2
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027117501&doi=10.1186%2fs13065-017-0312-2&partnerID=40&md5=4206eaa1c3de0b7b4c69a4ef6bc0cbd9
description Background: In the past few years, increased resistance of microorganisms towards antimicrobial agents become a serious health problem, so there is a need for the discovery of new antimicrobial agents. On the other hand, bis-pyrimidines possess various types of biological activity. In view of this, in the present study we have designed and synthesized a new series of bis-pyrimidine acetamides by Claisen-Schmidt condensation and screened for its in vitro antimicrobial and anticancer activities. Results: The synthesized bis-pyrimidine acetamide derivatives were confirmed by IR, 1H/13C-NMR, Mass spectral studies as well C, H, N analyses. The synthesized compounds were evaluated for their in vitro antimicrobial potential against Gram positive (Staphylococcus aureus and Bacillus subtilis); Gram negative (Escherichia coli, Pseudomonas aeruginosa and Salmonella enterica) bacterial and fungal (Candida albicans and Aspergillus niger) strains by tube dilution technique and the minimum inhibitory concentration (MIC) recorded in μmol/mL was comparable to reference drugs, cefadroxil (antibacterial) and fluconazole (antifungal). The in vitro anticancer activity (IC50 value) determined against human colorectal carcinoma (HCT116) cancer cell line by Sulforhodamine B (SRB) technique and 5-fluorouracil used as reference drug. Conclusions: The biological study demonstrated that compounds 3, 13, 16, 17 and 18 were found to be most active antimicrobial agents with best MIC values than the cefadroxil (antibacterial) and fluconazole (antifungal) and compounds 12, 16 and 18 found to have better anticancer activity against human colorectal carcinoma (HCT116) cancer cell line with best IC50 value than the 5-fluorouracil (anticancer).[Figure not available: see fulltext.] © 2017 The Author(s).
publisher BioMed Central Ltd.
issn 1752153X
language English
format Article
accesstype All Open Access; Gold Open Access
record_format scopus
collection Scopus
_version_ 1809677907831816192